Skip to main content
01942 271 746
Apply Online

May 2023 Shareholder Update Presentation

May 2023 Shareholder Update Presentation

Date: 10 May 2023 2:00 PM

The Company thanks everyone for joining us for our May 2023 Shareholder Update Presentation. If you didn’t get a chance to join us or would like to revisit the presentation, please find below a link to the Presentation PDF and the video recording of the event.

 

Portfolio Company Updates


Mark Perera, Founder and Chairman of Old St Labs t/a Vizibl


Arthur Wakeley, Managing Director of Celadon Pharmaceuticals Plc

Important information
This information is of a general nature and is not a prospectus. Investors should only subscribe for shares based on information in the prospectus and Key Information Document (KID) which can be obtained from our website. The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice. The value of investments and/or any income arising from them may fluctuate. Past performance is not necessarily a guide to future performance.

Contact Us

Online form

If you have any questions about anything you’ve seen on our website then please get in touch. We are here to help. Normal office hours are weekdays 9.00am to 5.00pm. The office is not open on weekends or bank holidays.
  • Hidden

  • Before submitting this form, please confirm that you have read and agree with our website Terms & Conditions

  • This field is for validation purposes and should be left unchanged.

Or via phone or email on

01942 271 746

Please Note

The contents of this website are a financial promotion and are approved by Seneca Partners Limited of 9 The Parks, Newton-le-Willows WA12 0JQ.

The value of an investment in the Seneca Capital Growth VCT plc may go down as well as up, in which case an investor may not get back the amount invested. The share prices quoted may not reflect the VCT’s net asset value.

Seneca Growth Capital VCT plc’s investments include holdings in private companies which are small and which carry an above-average level of risk to capital and whose shares may not be readily marketable. It also invests in companies quoted on the Alternative Investment Market (AIM) of the London Stock Exchange (LSE) which is generally for smaller, emerging companies and carries a higher level of risk to capital than the main market of the LSE.  The past performance of Seneca Growth Capital VCT plc is not a guide to the future performance.

Any tax reliefs available to investors are dependent on personal circumstances and may change in the future. The tax reliefs available to certain investors in Seneca Growth Capital VCT plc are dependent on the VCT maintaining Inland Revenue approval. If this approval is withdrawn, the VCT will lose its status and all tax reliefs are likely to be cancelled. Investors must retain their VCT shares for five years to retain the up-front income tax relief. The tax rules and regulations governing VCTs are subject to change.

An investment in Seneca Growth Capital VCT plc may not be suitable for all investors. Investors should seek advice from a qualified financial adviser. Nothing on this website should be construed as investment or tax advice.

Seneca Partners Ltd is authorised and regulated by the Financial Conduct Authority.

Continue to site